GO Advisors Meeting: Difference between revisions

From GO Wiki
Jump to navigation Jump to search
mNo edit summary
Line 43: Line 43:
#Jane Lomax
#Jane Lomax
#Chris Mungall
#Chris Mungall
#Simon Twigger
#Tanya Berardini
*GO Advisors
*GO Advisors
#<b>Larry Hunter</b>
#<b>Larry Hunter</b>
Line 51: Line 53:
#<b>Craig Neville-Manning</b> (unable to attend)
#<b>Craig Neville-Manning</b> (unable to attend)
#<b>Peter Tarczy-Harnach</b>
#<b>Peter Tarczy-Harnach</b>
#<b>Ian Dix</b>
#<b>Ian Dix</b> (Courtland Yockey attending)
*Other possible attendees
*Other possible attendees
#Monte Westerfield?
#Monte Westerfield?

Revision as of 14:02, 21 August 2006

Aim of the meeting

The main focus of this meeting is to obtain our advisors views and perspectives on the work we have planned (i.e. the new proposal) and the approach we are taking to accomplish our aims.

Please add items below that you think need to be presented. When possible, please put your request in priority rank order:

  1. Who is the target audience for the annotation tool?
  2. How does the idea of an annual functional annotation tool bake-off sound to you? How would you approach it? Can it be used to keep orphaned genomes up-to-date?
  3. Almost everyone agrees that the GO Consortium should develop an annotation tool, but once we begin asking questions about what the tool should do, it becomes clear that every group has very different ideas about what such a tool should do. Groups within the GO tend to advocate for the development of a tool that satisfies their own research efforts at the moment, because that is the immediate need as they understand it. Could the advisors suggest a way of determining which of these special-purpose applications are best for the GO user community as a whole, so that we can decide how to focus our development efforts? What's the best way to encourage inter-group communication to foster collaboration on tools and minimize redundant development efforts? How can we decide whether specific, highly targeted annotation tools or general, lowest-common-denominator annotation tools would be most useful to our user community?
  1. How can we help community scientists to get credit for their GO work? Could we publish a short account of the work of individual content meetings with all experts having author credit? Could groups providing manual annotation of their own gene products of interest get a small publication giving an account of their contribution and of possible applications?

Agenda

In order to meet our objectives, we need to present all of the material in the morning.

Morning presentations will be 30 minutes, plus 15 minutes for questions

The workshop will consist of these sessions:

  • GO presentations: New initiatives in the renewal
    • 8:00AM: Introductions (picture on display and circle everyone)
    • 8:15AM: Ontology Developments (technical - Chris; biology - David & Midori)
    • 9:00AM: Reference Genomes (Michael & Rex)
    • 9:45AM: Outreach (Jen)
    • 10:30AM: 15 minute Break
    • 10:45AM: Advocacy (Eurie & Jane)
    • 11:30AM: New management structure (Suzi)
    • 12:15PM: Summary of issues we face: pink sheets and more (Judy)
  • 1:00PM - 2:00PM, working lunch for advisors and GO-top
  • 2:00PM - 3:30PM, advisors powwow
  • 3:30PM - 5:00PM, feedback from advisors
  • 6:00PM dinner with everyone

Participants

  • GO representatives
  1. Michael Ashburner
  2. Judy Blake
  3. Eurie Hong
  4. Suzi Lewis
  5. Rex Chisholm
  6. Jen Clark
  7. Midori Harris
  8. David Hill
  9. Ben Hitz (representing production services)
  10. Jane Lomax
  11. Chris Mungall
  12. Simon Twigger
  13. Tanya Berardini
  • GO Advisors
  1. Larry Hunter
  2. Lynette Hirschman
  3. Barry Smith
  4. David States
  5. Mike Tyers
  6. Craig Neville-Manning (unable to attend)
  7. Peter Tarczy-Harnach
  8. Ian Dix (Courtland Yockey attending)
  • Other possible attendees
  1. Monte Westerfield?
  2. Peter Good?

Venue

Accommodation: Silver Cloud Inns / Seattle-University Village

 5036 25th Avenue NE
 Seattle, WA 98105
 Phone: 206-526-5200